InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,099.96
(
1.02%
)
US TECH 100
17,244.80
(
1.57%
)
Dow Jones
38,239.66
(
0.40%
)
Brent Oil
88.17
(
0.00%
)
Bitcoin
62,847.09
(
-1.40%
)
Post# of 251621
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119499
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Double_Bagel post# 190770

Saturday, 05/02/2015 11:15:54 AM

Saturday, May 02, 2015 11:15:54 AM

Post# of 251621
Re: MNTA CC notes /Glatopa pricing

The $35K Glatopa price mentioned on the CC for modeling purposes is a 25% discount to Teva’s actual realized price of $47K for US patient taking branded 20mg Copaxone for one year.

The $47K figure comes from multiplying Teva’s list price of $73K by 80% to account for rebates and then multiplying by another 80% to account for non-compliance (i.e. patients who have treatment lapses from not filling their prescriptions).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up